Tag: MVA monkeypox vaccine repurposed for sars-cov-2
Monkeypox vaccine MVA repurposed for Covid-19
A new comparison study in PNAS from NIAID intramural scientists clearly shows that for SARS-CoV-2, nasal vaccination – particularly in two doses – has clear advantages over muscular delivery in laboratory mice. More...